Preclinical recapitulation of antiangiogenic drug clinical efficacies using models of early or late stage breast cancer metastatis.
about
Anti-angiogenic alternatives to VEGF blockadeBreast cancer brain metastases: biology and new clinical perspectivesHigh and low frequency subharmonic imaging of angiogenesis in a murine breast cancer modelPersonalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013Sunitinib significantly suppresses the proliferation, migration, apoptosis resistance, tumor angiogenesis and growth of triple-negative breast cancers but increases breast cancer stem cells.Epithelial-mesenchymal plasticity is a decisive feature for the metastatic outgrowth of disseminated WAP-T mouse mammary carcinoma cellsFunctional Coupling of Human Microphysiology Systems: Intestine, Liver, Kidney Proximal Tubule, Blood-Brain Barrier and Skeletal Muscle.Metronomics: towards personalized chemotherapy?Mouse models of metastasis: progress and prospects.Efficacy of Cotargeting Angiopoietin-2 and the VEGF Pathway in the Adjuvant Postsurgical Setting for Early Breast, Colorectal, and Renal Cancers.Monitoring vascular normalization induced by antiangiogenic treatment with (18)F-fluoromisonidazole-PET.The Challenges of Modeling Drug Resistance to Antiangiogenic Therapy.A hypoxia- and telomerase-responsive oncolytic adenovirus expressing secretable trimeric TRAIL triggers tumour-specific apoptosis and promotes viral dispersion in TRAIL-resistant glioblastoma.Inhibitory effect and molecular mechanism of mesenchymal stem cells on NSCLC cells.
P2860
Q26775947-5AD616A3-2481-47C9-A47D-022694552487Q28078998-140A2749-1676-457E-833C-950A2E41E0ECQ30375548-F558B20E-21B5-4F0A-BDD5-BD37056B3CF6Q30543788-AD11D721-F561-42A9-B96D-AA6E8D7CE2FAQ33726477-CBAA8E2C-387E-429D-AB73-363D6D98711AQ35238838-E3D0E2BF-374D-4E76-8AA3-5B6547B073C4Q37630442-76CAB789-15EE-47DF-9979-CC57116ABCA1Q38218923-F4B23B54-3EED-4B6C-B2DA-4842CF8F2EB6Q41664785-28A109CD-E6CE-472C-BDE9-3EE505FD1902Q42067472-95CDBC98-755A-4A66-8EC4-BFB992CDF4D9Q42282877-4500D8A5-6F0A-4120-8739-EAB0CC72879FQ44456046-A41D6730-EB6C-4047-82E3-1F43633FB83EQ47549547-000B6B21-4F26-4FD7-9B50-37A658C842EAQ47830442-B0C9A55E-606B-46CC-ADF8-14A3C917A20F
P2860
Preclinical recapitulation of antiangiogenic drug clinical efficacies using models of early or late stage breast cancer metastatis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Preclinical recapitulation of ...... tage breast cancer metastatis.
@en
type
label
Preclinical recapitulation of ...... tage breast cancer metastatis.
@en
prefLabel
Preclinical recapitulation of ...... tage breast cancer metastatis.
@en
P2093
P1433
P1476
Preclinical recapitulation of ...... stage breast cancer metastatis
@en
P2093
Christina R Lee
Giulio Francia
Robert S Kerbel
P304
P356
10.1016/J.BREAST.2013.07.011
P478
22 Suppl 2
P577
2013-08-01T00:00:00Z